Ticker Scorecard - AMPH Basics Company: Amphastar Pharmaceuticals, Inc. IPO Date: June 25, 2014 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $1.84B Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 1.67% Avg Daily Range (30 D): $0.70 | 1.77% Avg Daily Range (90 D): $0.67 | 1.51% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .48M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 48 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 2,126 Avg Inst. Trade: $1.78M Avg Inst. Trade (30 D): $2.5M Avg Inst. Trade (90 D): $2.18M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.06M Avg Closing Trade (30 D): $4.31M Avg Closing Trade (90 D): $3.27M Avg Closing Volume: 66.78K     News Sep 6, 2024 @ 5:46 PM JP Morgan Shows Most Interest In Teva, Organon As ... Source: Vandana Singh Jul 23, 2024 @ 5:01 PM HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 202... Source: N/A May 30, 2024 @ 6:06 AM Amphastar Pharmaceuticals: Buy When Fear Is Overbl... Source: James Long May 15, 2024 @ 12:36 PM Implied Volatility Surging for Amphastar (AMPH) St... Source: Zacks Equity Research May 8, 2024 @ 9:15 PM Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $3.25 $.83 $.77 Diluted EPS $3.01 $.78 $.73 Revenue $ 723.55M $ 191.21M $ 182.39M Gross Profit $ 383.35M $ 101.94M $ 95.17M Net Income / Loss $ 157.72M $ 40.43M $ 37.95M Operating Income / Loss $ 214.26M $ 57.05M $ 55.22M Cost of Revenue $ 340.2M $ 89.27M $ 87.23M Net Cash Flow $ -78.69M $ 2.5M $ -11.53M PE Ratio 11.89